Supplementary Figure 1 from Alternate Splicing of the P53 Inhibitor HDMX Offers a Superior Prognostic Biomarker Than P53 Mutation in Human CancerKristiaan Lenos,Anna M. Grawenda,Kirsten Lodder,Marieke L. Kuijjer,Amina F.A.S. Teunisse,Emmanouela Repapi,Lukasz F. Grochola,Frank Bartel,Pancras C.W. Hogendoorn,Peter Wuerl,Helge Taubert,Anne-Marie Cleton-Jansen,Gareth L. Bond,Aart G. Jochemsencrossref(2023)引用 0|浏览31暂无评分关键词mRNA modificationAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要